Over last decade, Elfin has established itself in emerging markets, also known as RoW (Rest of the World) with presence in more than 50 countries spread across Africa, CIS, Middle East, Latin America and South East Asia in the branded generic space.Our presence spreads across wide range of therapeutic segments such as Anti-Malarial, Anti-biotic, Cardiovascular, Dermatology, Orthopedic, Gastroenterology, General Health, Gynecology, Male Erectile Dysfunction (MED) and Pediatric and our brands enjoy leadership position in many of these segments.
Out of the 50 countries we operate in, Elfin has ground presence through its field force in over 30 countries where we aggressively promote our brands taking them to leadership positions.
With the objective of building sustainable and scalable business model, we have been continuously filing product registration dossiers in different countries in various therapeutic segments. Currently, Elfin holds product registrations of over 1,400 products and another 1,300 & above products are awaiting approvals in various countries. Besides gaining market share from existing products, new product launches which are awaiting approvals will ensure sustained growth in years to come.